Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-16

Clinical Trial Update: Montelukast in Modulating Exacerbations of Asthma in Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated montelukast for reducing exacerbations in children with asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

Sponsor: Firestone Institute for Respiratory Health | Conditions: Asthma | Phase 4 | Status: COMPLETED